a day ago
MRK
AnalystsTerence FlynnTerence Flynn's Stock Forecasts
AnalystsTerence Flynn
Sectors:
Analyst Ranking
Top 8%
#373 out of 5150 analysts
Average Return
+15.5%
Win Rate
59%71 out of 120
Risk vs Reward
Poor
Good
Terence Flynn's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcus Biosciences IncRCUS | +160.02% | $8.28 | $21.53 | 2025-05-09 - 2025-12-12 | Strong Buy |
Translate Bio IncTBIO1 | +147.91% | $15.07 | $37.36 | 2020-10-05 - 2021-09-14 | Strong Buy |
Alumis IncALMS | +141.89% | $4.75 | $11.49 | 2025-08-15 - 2025-12-12 | Strong Buy |
Blueprint Medicines CorpBPMC | +140.20% | $41.34 | $99.30 | 2017-03-13 - 2018-03-13 | Strong Buy |
Eli Lilly & CoLLY | +139.90% | $314.17 | $753.68 | 2023-03-01 - 2024-02-29 | Strong Buy |
Terence Flynn Analyst Color
Get additional color on Terence Flynn's coverage of popular stocks
a day ago
GPCR
a day ago
ABBV
19 days ago
LLY
a month ago
LLY
2 months ago
LLY
5 months ago
JNJ
5 months ago
RPRX
5 months ago
JNJ
5 months ago
LLY
8 months ago
ABBV
8 months ago
JNJ
8 months ago
LLY
8 months ago
JNJ
8 months ago
ABBV
10 months ago
MRK
a year ago
JNJ
a year ago
ABBV
a year ago
LLY
a year ago
RPRX
a year ago
ABBV
a year ago
LLY
2 years ago
PFE
2 years ago
LLY
2 years ago
PFE
Terence Flynn's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Johnson & JohnsonJNJ | 26 | Hold | $197.00 | -6.89% | Maintains | a day ago |
Pfizer IncPFE | 20 | Hold | $28.00 | +8.32% | Maintains | a day ago |
Bristol Myers Squibb CoBMY | 11 | Strong Sell | $37.00 | -29.40% | Maintains | a day ago |
Merck & Co IncMRK | 19 | Hold | $102.00 | +1.69% | Maintains | a day ago |
Structure Therapeutics IncGPCR | 2 | Strong Buy | $125.00 | +86.40% | Maintains | a day ago |
Amgen IncAMGN | 11 | Hold | $304.00 | -4.32% | Maintains | a day ago |
Abbvie IncABBV | 19 | Strong Buy | $269.00 | +20.45% | Maintains | a day ago |
Vertex Pharmaceuticals IncVRTX | 3 | Strong Buy | $564.00 | +24.77% | Maintains | 8 days ago |
Eli Lilly & CoLLY | 21 | Strong Buy | $1,290.00 | +25.55% | Maintains | 19 days ago |
Biohaven LtdBHVN | 4 | Strong Buy | $26.00 | +125.50% | Maintains | 25 days ago |
Organon & CoOGN | 11 | Hold | $9.00 | +25.52% | Maintains | a month ago |
Nurix Therapeutics IncNRIX | 6 | Hold | $15.00 | -21.34% | Maintains | 2 months ago |
Royalty Pharma PLCRPRX | 13 | Strong Buy | $54.00 | +40.66% | Maintains | 2 months ago |
Biontech SeBNTX | 5 | Strong Buy | $131.00 | +38.17% | Maintains | 2 months ago |
United Therapeutics CorpUTHR | 11 | Hold | $435.00 | -11.94% | Maintains | 2 months ago |
Alumis IncALMS | 2 | Strong Buy | $22.00 | +91.47% | Maintains | 4 months ago |
Arcus Biosciences IncRCUS | 8 | Strong Buy | $23.00 | +6.83% | Maintains | 4 months ago |
Arvinas IncARVN | 8 | Hold | $11.00 | -12.56% | Maintains | 7 months ago |
Crispr Therapeutics AgCRSP | 7 | Strong Sell | $32.00 | -43.54% | Maintains | 10 months ago |
Intellia Therapeutics IncNTLA | 5 | Hold | $11.00 | +21.95% | Downgrades | a year ago |
Blueprint Medicines CorpBPMC | 5 | Strong Buy | $168.00 | N/A | Maintains | 2 years ago |
C4 Therapeutics IncCCCC | 5 | Hold | $8.00 | N/A | Maintains | 2 years ago |
Revance Therapeutics IncRVNC | 7 | Hold | $12.00 | N/A | Maintains | 2 years ago |
Neuehealth IncNEUE | 1 | Strong Buy | $2,880.00 | N/A | Initiates Coverage On | 4 years ago |
Biogen IncBIIB | 2 | Hold | $436.00 | N/A | Maintains | 4 years ago |
Translate Bio IncTBIO1 | 1 | Strong Buy | $342.00 | N/A | Initiates Coverage On | 5 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | $40.00 | N/A | Upgrades | 7 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Fibrogen IncFGEN | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Bioverativ IncBIVV | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.